Hospitalized cardiovascular events in patients with diabetic macular edema

BMC Ophthalmology

Volumn 12, Issue 1, 2012, Pages

  Nguyen Khoa, Bao Anh ^a   Goehring, Earl L ^a   Werther, Winifred ^b,c   Fung, Anne E ^c   Do, Diana V ^d   Apte, Rajendra S ^e   Jones, Judith K ^a  

^a The Degge Group Ltd   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

^c Pacific Eye Associates Ltd   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; COMPLICATION; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INSURANCE; MACULAR EDEMA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; MACULAR EDEMA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84861542059     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-12-11     Document Type: Article

References (26)

1. Ghafour IM, Allan D, Foulds W: Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983, 67:209-213. (Pubitemid 13114741)
2. Brown JB, Pedula KL, Summers KH: Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 2003, 26:2637-2642. (Pubitemid 37055446)
3. Camici PG, Crea F: Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
4. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörä là K, Laakso M: Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996, 19:1445-1448.
5. van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, Kofinis A, Rottiers R, Porta M, Chaturvedi N: EURODIAB prospective compications study: Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005, 28:1383-1389. (Pubitemid 40756701)
6. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong TY: Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 2007, 38:398-401. (Pubitemid 46184313)
7. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G: Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med 2008, 25:45-50.
8. Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ: Retinopathy predicts coronary heart disease mortality. Heart 2009, 95:391-394.
9. Cheung N, Wong TY: Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008, 27:161-176.
10. Klein R, Klein BE, Moss SE, Cruickshanks KJ: Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999, 117:1487-1495. (Pubitemid 29536476)
11. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY: Diabetic retinopathy and the risk of coronary heart disease: the atherosclerosis risk in communities study. Diabetes Care 2007, 30:1742-1746. (Pubitemid 47036346)
12. Ingenix: ICD-9-CM Professional for Hospitals, Volumes 1, 2, & 3, Fullsize Version. Salt Lake City, Utah: Thomson Delmar Learning; 2007.
13. International Classification of Diseases: Ninth Revision, Clinical Modification. Washington DC: US Department of Health and Human Services, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services; 2004.
14. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
15. D'Hoore W, Sicotte C, Tilquin C: Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993, 32:382-387. (Pubitemid 24001924)
16. Goldstein LB, Samsa GP, Matchar DB, Horner RD: Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004, 35:1941-1945. (Pubitemid 38971880)
17. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B: A midlife stroke surge among women in the United States. Neurol 2007, 69:18981907.
18. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000, 342:381-389.
19. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713.
20. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE: The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009, 116:497-503.
21. Dale AC, Midthjell K, Nilsen TI, Wiseth R, Vatten LJ: Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway. Eur Heart J 2009, 30:1372-1377.
22. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989, 96:1501-1510. (Pubitemid 19250961)
23. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984, 102:520-526. (Pubitemid 14127838)
24. Bearelly S, Mruthyunjaya P, Tzeng JP, Suer IJ, Shea AM, Lee JT, Kowalski JW, Curtis LH, Schulman KA, Lee PP: Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol 2008, 126:986-989. (Pubitemid 352008384)
25. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR, Diabetic Retinopathy Clinical Research Network: A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007, 114:1860-1867.
26. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002, 105:373-379. (Pubitemid 34106188)